Arevalo J Fernando, Garcia Reinaldo A, Wu Lihteh, Rodriguez Francisco J, Dalma-Weiszhausz Jose, Quiroz-Mercado Hugo, Morales-Canton Virgilio, Roca Jose A, Berrocal Maria H, Graue-Wiechers Federico, Robledo Violeta
Retina and Vitreous Service, Clinica Oftalmológica Centro Caracas, Venezuela.
Retina. 2008 Oct;28(8):1044-52. doi: 10.1097/IAE.0b013e3181744153.
To evaluate the complications after radial optic neurotomy (RON) for central retinal vein occlusion (CRVO).
Seventy-three consecutive patients (73 eyes) with CRVO who were treated with RON participated in a retrospective, uncontrolled, interventional, multicenter case series at 7 institutions from 6 countries.
In the ischemic CRVO group (n = 53), 32% of eyes had an improvement in best-corrected visual acuity (BCVA) (mean, 5.5 lines), 35.8% had worse BCVA (mean, 6.4 lines), and 32% had BCVA that remained the same after RON. In the nonischemic CRVO group (n = 20), 50% of eyes had an improvement in BCVA (mean, 6.5 lines), 15% had worse BCVA (mean, 4.3 lines), and 35% had BCVA that remained the same after RON. Complications occurred in 71.2% of cases, including cataract in 17 eyes (23.2%), vitreous hemorrhage in 16 eyes (20.5%), persistent macular edema in 15 eyes (20.5%), neovascular glaucoma in 7 eyes (9.5%), anterior segment neovascularization in 5 eyes (6.8%), retinal detachment in 3 eyes (4.1%), and phthisis bulbi, choroidovitreal neovascularization, central retinal artery perforation, and optic nerve atrophy in 1 eye (1.3%) each.
RON may improve visual acuity in some eyes with CRVO, but complications are common. In our series, surgery by itself did not seem to improve the outcome of CRVO when compared with its natural history.
评估视网膜中央静脉阻塞(CRVO)行放射状视神经切开术(RON)后的并发症。
连续73例(73眼)接受RON治疗的CRVO患者参与了一项来自6个国家7家机构的回顾性、非对照、介入性、多中心病例系列研究。
在缺血性CRVO组(n = 53)中,32%的患眼最佳矫正视力(BCVA)有所改善(平均提高5.5行),35.8%的患眼BCVA变差(平均下降6.4行),32%的患眼RON术后BCVA保持不变。在非缺血性CRVO组(n = 20)中,50%的患眼BCVA有所改善(平均提高6.5行),15%的患眼BCVA变差(平均下降4.3行),35%的患眼RON术后BCVA保持不变。71.2%的病例发生了并发症,包括17眼(23.2%)出现白内障,16眼(20.5%)出现玻璃体积血,15眼(20.5%)出现持续性黄斑水肿,7眼(9.5%)出现新生血管性青光眼,5眼(6.8%)出现眼前段新生血管形成,3眼(4.1%)出现视网膜脱离,各有1眼(1.3%)出现眼球痨、脉络膜玻璃体新生血管形成、视网膜中央动脉穿孔和视神经萎缩。
RON可能使部分CRVO患眼的视力得到改善,但并发症很常见。在我们的系列研究中,与CRVO的自然病程相比,手术本身似乎并未改善其预后。